Skip to main content
. 2022 Apr 13;12:6181. doi: 10.1038/s41598-022-10220-0

Table 1.

Phenotype and clinical severity of patients with MFN2 mutations.

Mutation Patient # Age at onset Age at review Sex CMTESv2 CMTESv2-R Ambulation Motor symptoms Sensory symptoms
R94Q 01–1 3 y 22 y M 13 18 Ambulatory (bilateral support, AFOs) + +
R104W 02–1 1 y 5 y M 26 (CMTPeds) / Ambulatory (AFOs) +
03–1 14 y 55 y M 18 22 Ambulatory (bilateral support) + +
03–2 2 y 23 M 16 20 Non-ambulatory +
03–3 4 y 20 M 18 24 Non-ambulatory + +
T236M 04–1 5 y 8 y M 12 (CMTPeds) / Ambulatory (plantars) +
S249C 05–1 17 y 39 y F 7 8 Ambulatory (autonomous) +
R280H 06–1 69 y 77 y F 9 12 Ambulatory (unilateral support) +
07–1 48 y 76 y F 14 19 Ambulatory (bilateral support) + +
08–1 58 y 71 y M 3 3 Ambulatory (autonomous) +
K357E 09–1 1 y 23 y F 19 26 Non-ambulatory + +
A383V 10–1 7 y 48 y F 12 13 Ambulatory (AFOs) +
10–2 12 y 58 y F 11 16 Ambulatory (walking aids) + +

AFO ankle–foot orthosis, CMTES Charcot–Marie–Tooth examination scale, CMTES-R Rasch analysis-weighted CMTES, CMTPeds CMT Pediatric Scale.